Scott Stankey

Scott is a serial biotech entrepreneur, co-founding Bramante Biologics, a Y Combinator-backed company, to establish modular microfactories for domestic pharmaceutical drug manufacturing. This venture aims to produce AI-designed drugs faster, enhance biodefense capabilities, and strengthen the U.S. biomanufacturing supply chain. fondo+2

He previously co-founded Protein Evolution Inc. and served as its Chief Technology Officer, where he applied artificial intelligence and natural science to engineer enzymes capable of recycling plastic and textile waste. His work focused on developing scalable solutions to transform waste into reusable materials, contributing to a circular economy. forbes+2

With a strong academic background, Scott earned both a Master's and Bachelor's of Science in Mathematics from Yale University, achieving a perfect 4.00 GPA and receiving recognition for outstanding academic achievement. yale

His professional experience includes a period as an Associate at McKinsey & Company, where he was involved in training and deploying AI, indicating expertise in applying advanced analytical methods to business problems.

An avid golfer, Scott was a member of the National Collegiate Club Golf Association during his time at Yale, participating in multiple tournaments. nccga